← Back to Conditions

Nephroblastoma

disorder
SNOMED 302849000CUI C0027708

Overview

Source: MedlinePlus.gov, National Library of Medicine. Not a substitute for medical advice.

Treatments & Interventions

Doxorubicin hydrochloride

substance

Doxorubicin

substance

Vincristine

substance

Dactinomycin

substance

Vincristine sulphate

substance

Daunorubicin hydrochloride liposome

substance

Doxorubicin hydrochloride pegylated liposome

substance

Clinical Trials

5
Total Trials
4
Recruiting
1
With Results

Recent Trials

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

NCT04322318Phase 2Recruiting256 enrolled

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NCT04851119Phase 1/PHASE2Recruiting147 enrolled

Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor

NCT00352534Phase 3Active Not Recruiting808 enrolled

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

NCT03213652Phase 2Active Not Recruiting13 enrolled

Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation

NCT00336531Phase 4Completed100 enrolled
View all 5 trials on ClinicalTrials.gov

Signs & Symptoms

Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.

Abdominal mass
Very frequent (80-99%)HP:0031500
Abnormal tissue mass
Very frequent (80-99%)HP:0002664
Nephroblastoma
Very frequent (80-99%)HP:0002667
Abdominal discomfort
Frequent (30-79%)HP:0002027
Duplication of renal pelvis
Frequent (30-79%)HP:0005580
Macroscopic hematuria
Frequent (30-79%)HP:0012587
Abnormal uterus morphology
Occasional (5-29%)HP:0031105
Aniridia
Occasional (5-29%)HP:0000526
Cryptorchidism
Occasional (5-29%)HP:0000028
Decreased haemoglobin
Occasional (5-29%)HP:0001903
Ectopic kidney
Occasional (5-29%)HP:0000086
Fused kidneys
Occasional (5-29%)HP:0000085
Hemihypertrophy
Occasional (5-29%)HP:0001528
High blood pressure
Occasional (5-29%)HP:0000822
Hypercalcemia
Occasional (5-29%)HP:0003072
Hypospadias
Occasional (5-29%)HP:0000047
Liver cancer
Occasional (5-29%)HP:0002896
Lung cancer
Occasional (5-29%)HP:0100526
Lymph node hyperplasia
Occasional (5-29%)HP:0002716
Malaise
Occasional (5-29%)HP:0033834
Microhematuria
Occasional (5-29%)HP:0002907
Polyglobulia
Occasional (5-29%)HP:0001901
Pyrexia
Occasional (5-29%)HP:0001945
Reduced von Willebrand factor activity
Occasional (5-29%)HP:0008330
Varicocele
Occasional (5-29%)HP:0012871
Weight loss
Occasional (5-29%)HP:0001824
Difficulty breathing
Very rare (1-4%)HP:0002094

Related Conditions

GLOW syndrome(child)
Nephroblastoma of left kidney(child)
Nephroblastoma of right kidney(child)
Primary Wilms tumour(child)
Malignant neoplasm of kidney parenchyma(parent)

Quick Facts

SNOMED CT
302849000
UMLS CUI
C0027708
Fully Specified Name
Nephroblastoma (disorder)
Specialists
0
Diagnostic Biomarkers
0
HPO Phenotypes
27
Known Treatments
7
Clinical Trials
5
Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.